These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34589110)

  • 21. Investigation and verification of the clinical significance and perspective of natural killer group 2 member D ligands in colon adenocarcinoma.
    Ruan GT; Wang S; Zhu LC; Liao XW; Wang XK; Liao C; Yan L; Xie HL; Gong YZ; Gan JL; Gao F
    Aging (Albany NY); 2021 Apr; 13(9):12565-12586. PubMed ID: 33909599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma.
    Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC
    Int J Med Sci; 2020; 17(13):1879-1896. PubMed ID: 32788867
    [No Abstract]   [Full Text] [Related]  

  • 23. Integrative Proteo-Genomic Analysis for Recurrent Survival Prognosis in Colon Adenocarcinoma.
    Ai F; Wang W; Liu S; Zhang D; Yang Z; Liu F
    Front Oncol; 2022; 12():871568. PubMed ID: 35847888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Value analysis of
    Zhang Y; Gao T; Wu M; Xu Z; Hu H
    Transl Cancer Res; 2024 Jun; 13(6):2877-2891. PubMed ID: 38988920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Construction of a prognostic risk model of colorectal adenocarcinoma through integrated analysis of RNA-binding proteins.
    Liu X; Lv Q; Jing Z; Long X; Yi R; Yang D; Zhao X
    Transl Cancer Res; 2021 May; 10(5):1962-1974. PubMed ID: 35116519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Copper metabolism patterns and tumor microenvironment characterization in colon adenocarcinoma.
    Lin J; Luo B; Yu X; Yang Z; Wang M; Cai W
    Front Oncol; 2022; 12():959273. PubMed ID: 36203457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Combined four-mRNA Signature Associated with Lymphatic Metastasis for Prognosis of Colorectal Cancer.
    Li X; Zhang Q; Zhao L; Jiang L; Qi A; Wei Q; Song X; Wang L; Zhang L; Zhao Y; Lv X; Wei M; Zhao L
    J Cancer; 2020; 11(8):2139-2149. PubMed ID: 32127941
    [No Abstract]   [Full Text] [Related]  

  • 28. A New RBPs-Related Signature Predicts the Prognosis of Colon Adenocarcinoma Patients.
    Chang K; Yuan C; Liu X
    Front Oncol; 2021; 11():627504. PubMed ID: 33767995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systematic analysis of the function and prognostic value of RNA binding proteins in Colon Adenocarcinoma.
    Qi X; Liu Z; Zhang Q; Yang M; Wan Y; Huang J; Xu L
    J Cancer; 2021; 12(9):2537-2549. PubMed ID: 33854615
    [No Abstract]   [Full Text] [Related]  

  • 30. Identification and validation of novel prognostic fatty acid metabolic gene signatures in colon adenocarcinoma through systematic approaches.
    Zhang H; Cheng W; Zhao H; Chen W; Zhang Q; Yu QQ
    Oncol Res; 2023; 32(2):297-308. PubMed ID: 38186579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification prognosis-associated immune genes in colon adenocarcinoma.
    Miao Y; Wang J; Ma X; Yang Y; Mi D
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33140821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishment of lactate-metabolism-related signature to predict prognosis and immunotherapy response in patients with colon adenocarcinoma.
    Zou Z; Chai Y; Li Q; Lin X; He Q; Xiong Q
    Front Oncol; 2022; 12():958221. PubMed ID: 36185199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of the Pyroptosis-Related Gene Signature and Risk Score Model for Colon Adenocarcinoma.
    Luo B; Lin J; Cai W; Wang M
    Front Genet; 2021; 12():771847. PubMed ID: 34938319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis and prognostic value of C-X-C motif chemokine ligand 1 in colon adenocarcinoma based on The Cancer Genome Atlas and Guangxi cohort.
    Gong YZ; Ma H; Ruan GT; Zhu LC; Liao XW; Wang S; Yan L; Huang W; Huang KT; Xie H; Zhu GZ; Wang XK; Liao C; Gao F
    J Cancer; 2021; 12(18):5506-5518. PubMed ID: 34405013
    [No Abstract]   [Full Text] [Related]  

  • 35. Discovered differentially expressed lncRNA AC010973.2 can act as a diagnostic and prognostic biomarker for colon adenocarcinoma.
    Liu X; Xiao C; Tan F; Yi R; Zhao X
    Transl Cancer Res; 2020 Oct; 9(10):6275-6286. PubMed ID: 35117237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Perspective of Diagnostic and Prognostic Values of Lipoxygenases mRNA Expression in Colon Adenocarcinoma.
    Ruan GT; Gong YZ; Zhu LC; Gao F; Liao XW; Wang XK; Zhu GZ; Liao C; Wang S; Yan L; Xie HL; Zhou X; Liu JQ; Shao MN; Gan JL
    Onco Targets Ther; 2020; 13():9389-9405. PubMed ID: 33061426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Novel Cancer Stemness-Related Signature for Predicting Prognosis in Patients with Colon Adenocarcinoma.
    Wang W; Xu C; Ren Y; Wang S; Liao C; Fu X; Hu H
    Stem Cells Int; 2021; 2021():7036059. PubMed ID: 34691191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypoxia-Related Gene-Based Signature Can Evaluate the Tumor Immune Microenvironment and Predict the Prognosis of Colon Adenocarcinoma Patients.
    He X; Ding J; Cheng X; Xiong M
    Int J Gen Med; 2021; 14():9853-9862. PubMed ID: 34938106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene expression and methylation profiles identified CXCL3 and CXCL8 as key genes for diagnosis and prognosis of colon adenocarcinoma.
    Zhao QQ; Jiang C; Gao Q; Zhang YY; Wang G; Chen XP; Wu SB; Tang J
    J Cell Physiol; 2020 May; 235(5):4902-4912. PubMed ID: 31709538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction and identification of immune genes related to the prognosis of patients with colon adenocarcinoma and its mechanisms.
    Chen S; Cao GD; Wei W; Yida L; Xiaobo H; Lei Y; Ke C; Chen B; Xiong MM
    World J Surg Oncol; 2020 Jun; 18(1):146. PubMed ID: 32600423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.